Search

everythinglearnresearchcommunity

for

Search:↓

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Bexarotene gel shows promise as a new treatment for alopecia areata.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

RCS-01 cell therapy is safe and improves skin gene expression.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

GLP-1 agonists may increase the risk of hair loss.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

The Rigenera method improved hair thickness and reduced hair loss in patients.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

GLP-1RA therapy may increase the risk of hair loss.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

RCS-01 is safe and may help rejuvenate aging skin.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.